Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: Can an association be confirmed?

Current Oncology

Volumn 16, Issue 3, 2009, Pages 21-25

  Ayeni, O ^b   Robinson, Andrew ^a  

^a Northeastern Ontario Regional Cancer Centre   (Canada)

^b NONE

Author keywords

Hormone therapy; Lung cancer; Prognostic factors; Sex

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; SKIN CANCER; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 70350576484     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 2005;128:370-381 (Pubitemid 40994497)
2. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20,561 cases. Ann Oncol 2002;13:1087-1093 (Pubitemid 34885010)
3. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-2038
4. Bain C, Feskanich D, Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004;96:826-834 (Pubitemid 38807603)
5. Henschke CI, Miettinen OS. Women's susceptibility to tobacco carcinogens. Lung Cancer 2004;43:1-5.
6. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-5803 (Pubitemid 24375208)
7. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: ct appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242:555-562
8. O'Connell JP, Kris MG, Gralla RJ, et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986;4:1604-1614
9. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542-2550 (Pubitemid 44917502)
10. Dubey S, Siegfried JM, Traynor AM. Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond. Lancet Oncol 2006;7:416-424
11. Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-1470 (Pubitemid 30802495)
12. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59-63. (Pubitemid 46630494)
13. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004;10 (pt 1):113-123 (Pubitemid 38114169)
14. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-1591 (Pubitemid 46890428)
15. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118(suppl 12B):148-154
16. Delaney MF. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 2006;194(suppl):S12-23.
17. Bond GL, Levine AJ. A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 2007;26:1317-1323
18. Márquez-Garbán DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 2007;72:135-143 (Pubitemid 46273500)
19. Kawai H, Ishii A, Washiya K, et al. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res 2005;25:4693-4698 (Pubitemid 41729532)
20. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovasc Disord 2006;6:40. (Pubitemid 44575749)
21. Rollin J, Iochmann S, Bléchet C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 2005;92:775-783 (Pubitemid 40460617)
22. Healton CG, Gritz ER, Davis KC, et al. Women's knowledge of the leading causes of cancer death. Nicotine Tob Res 2007; 9:761-768 (Pubitemid 47009231)
23. Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004; 104(pt 1):1042-1050 (Pubitemid 40458772)
24. Samant RS, Tucker TL. Analysis of cigarette smoking habits of cancer patients referred to the Northeastern Ontario Regional Cancer Centre. J Cancer Educ 2003;18:157-160
25. Palomares MR, Sayre JW, Shekar KC, Lillington LM, Chlebowski RT. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996; 78:2119-2126
26. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-980 (Pubitemid 26340751)
27. Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005;127:768-777 (Pubitemid 40775504)
28. Canadian Cancer Society and the National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto: Canadian Cancer Society; 2008. [Available online at: www.cancer.ca/Ontario/About%20cancer/Cancer%20statistics/ ∼/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/ pdf%20not%20in%20publications%20section/ Canadian%20Cancer%20Society%20Statistics%20PDF%202008-614137951.ashx; cited March 17, 2009]